205 seed medtech investors in the US

Top 5 seed medtech investors in the US, ranked by recent fund activity

Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (30: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (20; half of that when the sector is stated only), stage focus (15: all of it when seed is the only stage the firm states, split evenly when it states more), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (12) and completeness of the public record (8). Stage and regional focus are our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.

1. Digitalis Ventures

   Type: VC firm · HQ: New York, NY · Stages: Seed · Focus: Medtech, Healthtech, Biotech · Latest activity: Portfolio news, Nov 2026 · Private fund assets: $862M (SEC Form ADV)

   Portfolio news dated Nov 2026; $862M on file (SEC Form ADV); states medtech and medical devices as a focus; backs seed; names the US as where it invests; 8 named decision-makers on file.

2. Gore Range Capital

   Type: VC firm · HQ: Southlake, TX · Stages: Seed · Focus: Medtech, Healthtech, Biotech · Latest activity: New deal, Aug 2026 · Fund size on file: $250M (SEC Form D, 2026)

   Dated new deal in Aug 2026; $250M fund on file (SEC Form D, 2026); states medtech and medical devices as a focus; backs seed; names the US as where it invests; 1 named decision-maker on file.

3. Hatteras Venture Partners

   Type: VC firm · HQ: Durham, NC · Stages: Seed · Focus: Medtech, Healthtech, Biotech · Latest activity: New fund, Oct 2026 · Fund size on file: $250M (SEC Form D, 2023)

   Latest fund filing dated Oct 2026; $250M fund on file (SEC Form D, 2023); 23% of its observed portfolio is medtech and medical devices; backs seed; names the US as where it invests; 8 named decision-makers on file.

4. Safar Partners

   Type: VC firm · HQ: Cambridge, MA · Stages: Seed · Focus: Medtech, Healthtech, Industrial Tech, Biotech · Latest activity: New deal, Aug 2026 · Fund size on file: $300M (SEC Form D, 2023)

   Dated new deal in Aug 2026; $300M fund on file (SEC Form D, 2023); 17% of its observed portfolio is medtech and medical devices; backs seed; names the US as where it invests; 3 named decision-makers on file.

5. Heinz Ventures, LLC

   Type: VC firm · HQ: Memphis, TN · Stages: Pre-seed, Seed · Focus: Medtech, Healthtech · Latest activity: New deal, Aug 2026 · Fund size on file: $10M (SEC Form D, 2024)

   Dated new deal in Aug 2026; $10M fund on file (SEC Form D, 2024); 100% of its observed portfolio is medtech and medical devices; backs pre-seed, seed; names the US as where it invests; 5 named decision-makers on file.

First 25 of 205 seed medtech investors in the US

You are seeing 25 of 205. The full list adds 180 more investors and 1,001 named decision-makers.

How these 205 break down

Questions

Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to medtech and medical devices, seed and the US. Guide: how many investors to pitch. Markdown version of this page.